Autres langues

31/08 S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2026
29/05 S.C. Ropharma S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026
28/04 S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2025
24/12 S.C. Ropharma S.A. Reports Earnings Results for the Nine Months Ended September 30, 2025
29/08/25 S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2025
05/05/25 S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2024
30/08/24 S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2024
25/04/24 S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
31/08/23 S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023
27/04/23 S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2022
31/08/22 S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2022
28/04/22 S C Ropharma S A : OGSM & EGSM resolutions 28.04.2022
28/04/22 S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
23/03/22 S C Ropharma S A : Notice of O&EGSM 28.04.2022
27/01/22 S C Ropharma S A : 2022 Financial calendar
09/09/21 S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
28/04/21 S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2020
07/10/20 S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2020
11/03/19 S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2018
17/01/17 Ropharma Plans To Acquire Seven Pharmacy Units
15/11/16 ROPHARMA SA Reports Earnings Results for the Nine Months of 2016
27/11/15 S.C. Ropharma S.A.’s Equity Buyback announced on January 14, 2015 has expired.
14/05/15 Ropharma Announces Non-Consolidated Earnings Results for the Year 2014
14/01/15 S.C. Ropharma S.A. announces an Equity Buyback for 50,959,936 shares, representing 10% of its issued share capital.
14/01/15 S.C. Ropharma S.A. authorizes a Buyback Plan.
Aucun résultat pour cette recherche
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT